425 related articles for article (PubMed ID: 15342392)
1. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
2. The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation.
Lindberg SR; Olsson A; Persson AM; Olsson I
Exp Hematol; 2005 Feb; 33(2):189-98. PubMed ID: 15676213
[TBL] [Abstract][Full Text] [Related]
3. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a dominant-negative DeltaETS TEL/ETV6 isoform.
Sasaki K; Nakamura Y; Maki K; Waga K; Nakamura F; Arai H; Imai Y; Hirai H; Mitani K
Biochem Biophys Res Commun; 2004 May; 317(4):1128-37. PubMed ID: 15094386
[TBL] [Abstract][Full Text] [Related]
5. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
[TBL] [Abstract][Full Text] [Related]
6. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.
Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G
Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925
[TBL] [Abstract][Full Text] [Related]
7. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
8. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a new human ETS-family transcription factor, TEL2, that is expressed in hematopoietic tissues and can associate with TEL1/ETV6.
Potter MD; Buijs A; Kreider B; van Rompaey L; Grosveld GC
Blood; 2000 Jun; 95(11):3341-8. PubMed ID: 10828014
[TBL] [Abstract][Full Text] [Related]
10. The ETS factor TEL2 is a hematopoietic oncoprotein.
Carella C; Potter M; Bonten J; Rehg JE; Neale G; Grosveld GC
Blood; 2006 Feb; 107(3):1124-32. PubMed ID: 16234363
[TBL] [Abstract][Full Text] [Related]
11. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
[TBL] [Abstract][Full Text] [Related]
12. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
13. Mouse models in the study of the Ets family of transcription factors.
Bartel FO; Higuchi T; Spyropoulos DD
Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
[TBL] [Abstract][Full Text] [Related]
14. ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells.
Kuramoto K; Uesaka T; Kimura A; Kobayashi M; Watanabe H; Katoh O
Cancer Res; 2000 Jan; 60(2):425-30. PubMed ID: 10667597
[TBL] [Abstract][Full Text] [Related]
15. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
16. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation.
Morosetti R; Park DJ; Chumakov AM; Grillier I; Shiohara M; Gombart AF; Nakamaki T; Weinberg K; Koeffler HP
Blood; 1997 Oct; 90(7):2591-600. PubMed ID: 9326225
[TBL] [Abstract][Full Text] [Related]
17. Regulation of L-selectin expression by a dominant negative Ikaros protein.
Christopherson I; Piechoki M; Liu G; Ratner S; Galy A
J Leukoc Biol; 2001 Apr; 69(4):675-83. PubMed ID: 11310856
[TBL] [Abstract][Full Text] [Related]
18. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
19. Human EVI9, a homologue of the mouse myeloid leukemia gene, is expressed in the hematopoietic progenitors and down-regulated during myeloid differentiation of HL60 cells.
Saiki Y; Yamazaki Y; Yoshida M; Katoh O; Nakamura T
Genomics; 2000 Dec; 70(3):387-91. PubMed ID: 11161790
[TBL] [Abstract][Full Text] [Related]
20. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]